News | Radiology Imaging | August 17, 2017

Two organizations will conduct joint research at Houston Methodist Research Institute while Siemens provides latest in imaging and imaging IT technology 

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers

August 17, 2017 — Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge technology to Houston Methodist that is not currently available in the Texas Medical Center. This agreement will provide innovative, world-class medical technology to Houston Methodist Hospital and all of its community hospital facilities.

Under the terms of the agreement, the Houston Methodist Research Institute will be equipped with the latest technology in the areas of angiography, magnetic resonance imaging (MRI), computed tomography (CT), molecular imaging, imaging information technology (IT) and ultrasound. A focal point of the facility will be two interventional suites that incorporate a traditional hybrid CT/angiography suite with the latest in advanced imaging technology. The collaboration and access to advanced imaging technology provides an opportunity for seamless clinical translation, bringing treatments quickly from the lab to the patient’s bedside.

The two organizations also will enter into an agreement to conduct joint research at the Houston Methodist Research Institute, where Siemens Healthineers is also delivering an investigational 7T MR to be used for research only. Siemens Healthineers engineers will work at the Research Institute on new advancements in imaging with researchers from around the Texas Medical Center who will have access to the facility.

This agreement will make Siemens Healthineers a primary provider of diagnostic imaging equipment to all Houston Methodist campuses. With this agreement, Siemens Healthineers will provide a comprehensive coverage model, including onsite service engineers, a dedicated service manager and onsite research scientists.

“We are eager to start our work together and look forward to seeing the outcome of this promising collaboration,” said Marc Boom, M.D., president and CEO of Houston Methodist. “We also look forward to working with scientists at Siemens Healthineers who share our mission of leading medicine.”

For more information: www.usa.healthcare.siemens.com


Related Content

News | Clinical Trials

Aug.12,2026 — Mendaera Inc. has announced results from a peer-reviewed study showing that its FDA-cleared Focalist ...

Time August 17, 2026
arrow
Feature | Artificial Intelligence | Madhu Jahagirdar

Radiologists spend much of their day moving between different systems: One application to review images. Another to ...

Time August 17, 2026
arrow
News | X-Ray

Aug. 10, 2026 — Teledyne Technologies Inc. and Varex Imaging Corp. have jointly announced that they have entered into a ...

Time August 14, 2026
arrow
News | Breast Imaging

Aug. 13, 2026 – Perimeter Medical Imaging AI recently announced that Intermountain Health, the largest nonprofit health ...

Time August 14, 2026
arrow
News | FDA

Aug. 1, 2026 — Candelis recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time August 13, 2026
arrow
News | Artificial Intelligence

Aug. 10, 2026 — OSF HealthCare, a not-for-profit health system serving communities across Illinois and Michigan, and ...

Time August 12, 2026
arrow
News | Lung Imaging

Aug. 11, 2026 — Noah Medical has launched the Galaxy II software, the next evolution of its robotic-assisted ...

Time August 10, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
Subscribe Now